Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation — Yuen Ting Cheng (2025) | RDL Network
Treatment with trimetazidine is associated with a lower risk of incident and recurrent stroke in patients with both ischemic heart disease and AF. These findings will need to be confirmed in randomized controlled trials.
Yuriy Flomin, Simona Marcheselli, Nicola Mumoli, Alexandra Rimoldi, Elena Pinuccia Verrengia, Erika Schirinzi, Massimo Del Sette, Panagiotis Papamichalis, Apostolos Komnos, Nemanja Popovic, Marija Žarkov, Alessandro Rocco, Marina Diomedi, Elisa Giorli, Alfonso Ciccone, Brian Mac Grory, Karen L. Furie, Bruno Bonetti, Valentina Saia, Francesca Guideri, Maurizio Acampa, Giuseppe Martini,
Discussion(0)
No comments yet. Be the first to comment.